SavedAdd your journal

Journals / European Journal of Rheumatology / 2016 / Cilt: 3 - Sayı: 1

Ethylenediaminetetraacetic acid-dependent pseudothrombocytopenia in a patient with systemic lupus erythematosus and lupus nephritis

Metin ÖZGEN
Lütfi AKYOL
Soner ÖNEM
Mehmet SAYARLIOĞLU
Pages
36–37
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Pseudothrombocytopenia can occur in patients with SLE and LN and should be considered when diagnosing patients with thrombocytopenia without bleeding.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by several immunological abnormalities.
📊
Key Findings & Data:We wish to communicate the case of a patient with SLE and lupus nephritis (LN) who developed pseudothrombocytopenia.
💡
Conclusion & Impact:Pseudothrombocytopenia can occur in patients with SLE and LN and should be considered when diagnosing patients with thrombocytopenia without bleeding.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by several immunological abnormalities. We wish to communicate the case of a patient with SLE and lupus nephritis (LN) who developed pseudothrombocytopenia. Pseudothrombocytopenia can occur in patients with SLE and LN and should be considered when diagnosing patients with thrombocytopenia without bleeding.

🔖

Cite This Article

ÖZGEN, M., AKYOL, L., ÖNEM, S., SAYARLIOĞLU, M. (2022). Ethylenediaminetetraacetic acid-dependent pseudothrombocytopenia in a patient with systemic lupus erythematosus and lupus nephritis. European Journal of Rheumatology, Cilt: 3 - Sayı: 1, 36–37. https://ajindex.com/articles/511757

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. La Cava A. The busy life of regulatory T cells in systemic lupus erythematosus. Discov Med 2009; 8: 13-7.
  2. Kuwana M, Kaburaki J, Okazaki Y, Miyazaki H, Ikeda Y. Two types of autoantibody-mediated thrombocytopenia in patients with systemic lupus erythematosus. Rheumatology (Oxford) 2006; 45: 851-4. [CrossRef] Newman K, Owlia MB, El-Hemaidi I, Akhtari M. Management of immune cytopenias in patients with systemic lupus erythematosus - Old and new. Autoimmun Rev 2013; 12: 784-91. [CrossRef] Gschwandtner ME, Siostrzonek P, Bodinger C, Neunteufl T, Zauner C, Heinz G, et al. Docu- mented sudden onset of pseudothrombocyto- penia. Ann Hematol 1997; 74: 283-5. [CrossRef] Bizzaro N. EDTA-dependent pseudothrombo- cytopenia: a clinical and epidemiological study of 112 cases, with 10-year follow-up. Am J He- matol 1995; 50: 103-9. [CrossRef] Stiegler H, Fischer Y, Steiner S, Strauer BE, Re- inauer H. Sudden onset of EDTA-dependent pseudothrombocytopenia after therapy with the glycoprotein IIb/IIIa antagonist c7E3 Fab. Ann Hematol 2000; 79: 161-4. [CrossRef] Irisawa A, Kaise S, Kumada Y, Sato Y, Nishimaki T, Kasukawa R, et al. [A case of late-onset SLE complicated with EDTA-dependent pseudo- thrombocytopenia]. Ryumachi 1992; 32: 468- 74; discussion 72-3.
  3. Murayama T, Nakasaki S. [Pseudothrombocyto- penia caused by low molecular weight IgM in rheumatoid arthritis: a case report]. Nihon Nai- ka Gakkai Zasshi 1987; 76: 1105-8. [CrossRef] Lippi G, Plebani M. EDTA-dependent pseudo- thrombocytopenia: further insights and rec- ommendations for prevention of a clinically threatening artifact. Clin Chem Lab Med 2012; 50: 1281-5. [CrossRef] Schuff-Werner P, Steiner M, Fenger S, Gross HJ, Bierlich A, Dreissiger K, et al. Effective estimation of correct platelet counts in pseudothrombo- cytopenia using an alternative anticoagulant based on magnesium salt. Br J Haematol 2013; 162: 684-92. [CrossRef] 37